SANTA ANA, CA – BioLargo, Inc. – (UPTICK Newswire - August 25, 2015) – (OTCQB: BLGO) announced today that the following letter was delivered to its shareholders: Dear Shareholder, It…
Uptick Staff have been on the hunt this week for strong companies to feature, keeping our investor readership in mind, we've found another one. Islet Sciences, Inc. Read up below,…
For Medical Treatments of Incurable and Hard To Cure Diseases Including Cancer, Muscular Dystrophy, and Neurofibromatosis El Paso, TX, -- (UPTICK Newswire - September 29, 2015) -- Premier Biomedical, Inc…
San Diego, Calif., (UPTICK Newswire - September 24, 2015) – Innovus Pharmaceuticals, Inc., (“Innovus Pharma”) www.innovuspharma.com (OTC: BB: INNV) announced today it paid in full in cash it $384,000 note…
El Paso, TX - (UPTICK Newswire - September 21, 2015) - Premier Biomedical, Inc. (OTCQB: "BIEI") a research-based company discovering and developing medical treatments for a wide range of diseases in…
Innovus Expands its Current Agreement Eligible to Receive up to 94.55 Million Canadian Dollars in Upfront and Sales Milestone Payments plus Double-Digit Tiered Royalties San Diego, Calif., (UPTICK Newswire -…
The agreement will bring NovaBay’s innovative eyelid and lash hygiene product Avenova to hundreds of additional optometry offices including LensCrafters EMERYVILLE, Calif. – (UPTICK Newswire - September 16, 2015) -…
San Diego, Calif., (UPTICK Newswire - September 10 2015) – Innovus Pharmaceuticals, Inc. (“Innovus Pharma”) www.innovuspharma.com (OTCQB: INNV) announced today it has entered into an exclusive marketing and distribution agreement…
Chicago, IL - (UPTICK Newswire - September 8, 2015) - We initiate coverage on Innovus Pharmaceuticals, Inc. (“INNV”) with a strong buy rating and a price target of $0.80 per…
Orimed to be the First Partner to Launch EjectDelay® Outside the US SAN DIEGO, CA: (UPTICK Newswire - September 3, 2015) – Innovus Pharmaceuticals, Inc., (“Innovus Pharma” or the “Company)…
Chicago, IL - (UPTICK Newswire - August 26, 2015) - With M&A activity in biotech and pharmaceutical sectors accelerating, large and mid-size pharmaceutical corporations are in search of opportunities to…
BOUCHERVILLE, QC, (UPTICK Newswire - July 2, 2015) – Orimed Pharma announced today the availability of Zestra® and Uxor™ (sold in the US as EjectDelay®) for the Canadian market the…